Skip to main content
. Author manuscript; available in PMC: 2012 Sep 16.
Published in final edited form as: Vaccine. 2011 Jul 27;29(40):7058–7066. doi: 10.1016/j.vaccine.2011.07.028

TABLE 1.

HSV-2 peptide pools used in the IFN-γ ELISPOT assay

No. HSV-2 ORF ORF classa Common name ORF Length (aa) # peptidesb # pools # peptides/pool
1 US6 gp gD-2 393 96 1 96
2 RL2 IE ICP0 824 198 2 98,100
3 US1 IE ICP22 413 101 2 50,51
4 UL54 IE ICP27 512 126 2 63,63
5 RS1 IE ICP4 1,318 330 4 82,82,83,83
6 UL39 other ICP6 1,142 283 3 94,94,95
7 UL19 capsid VP5/ICP5 1,375 341 4 85,85,85,86
8 UL25 capsid 585 144 2 72,72
9 UL35 capsid VP26 112 26 1 26
10 UL46 tegument VP11/12 722 178 2 89,89
11 UL47 tegument VP13/14 696 172 2 86,86
12 UL49 tegument VP22 300 74 1 74
13 UL11 tegument 96 22 1 22
14 UL27 gp gB 904 224 3 74,87,63
15 UL29 other ICP8 1,196 297 3 99,99,99
16 US5 gp gJ 92 21 1 21
Totals 2,633 34 range: 21–100
a

Open reading frames (ORF) for study encoded glycoproteins (gp), immediate early (IE), capsid, tegument or other proteins.

b

15 mers overlapping by 11 amino acids (aa).